Scientific Inc. (OTCBB: MLSS), the recognized leader in advanced,
computer-controlled drug delivery technologies, will participate in the
American Academy of Dental Group Practice (?AADGP?) Conference in
Orlando, Florida, from January 26 – 29, 2011, at Booth #104, at the
Hilton Hotel in the Walt Disney World Resort.
Joseph D'Agostino, Chief Financial Officer said, ?As much of our sales
and marketing efforts have been geared towards group dental practices
with the hiring of Marvin Terrell as Domestic Director of Sales, we
believe the AADGP presents us a great opportunity to meet with decision
makers at these practices. We will have the opportunity to demonstrate
how our Single Tooth Anesthesia System (?STA?) can help group dental
practices differentiate themselves, increase their efficiency and
contribute to their growth and profits. Our dental hygienists will be on
hand to educate attendees on the STA system, and show them how it has
revolutionized the science of dentistry.?
About Milestone Scientific Inc.
Milestone Scientific is engaged in pioneering advanced
computer-controlled drug delivery technologies for the medical and
dental markets; and currently sells its award-winning products through a
global distribution network serving North America, Central and South
America, Asia, Africa and Europe. For more information on the STA
Single Tooth Anesthesia System® unit and other innovative Milestone
products, please visit the Company's web site found at www.milestonescientific.com
or follow the Company on Twitter @painlessdental or become a fan on
Facebook at Painless Dentistry.
Safe Harbor Statement
This press release contains forward-looking statements regarding the
timing and financial impact of Milestone's ability to implement its
business plan, expected revenues and future success. These statements
involve a number of risks and uncertainties and are based on assumptions
involving judgments with respect to future economic, competitive and
market conditions and future business decisions, all of which are
difficult or impossible to predict accurately and many of which are
beyond Milestone's control. Some of the important factors that could
cause actual results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure to
achieve expected revenue growth, changes in our operating expenses,
adverse patent rulings, FDA or legal developments, competitive
pressures, changes in customer and market requirements and standards,
and the risk factors detailed from time to time in Milestone's periodic
filings with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report for the year ended December 31,
2009. The forward looking-statements in this press release are based
upon management's reasonable belief as of the date hereof. Milestone
undertakes no obligation to revise or update publicly any
forward-looking statements for any reason.
Milestone Scientific Inc.
Joseph D'Agostino, 973-535-2717
LeVay & Rose, Inc.
Linda Decker, 212-564-4700